<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chaudhry SA</submitter><funding>NCATS NIH HHS</funding><funding>NHLBI NIH HHS</funding><pagination>1423-1432</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11877412</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>333(16)</volume><pubmed_abstract>&lt;h4>Importance&lt;/h4>Clinical decision-making in thrombotic disorders is impeded by long-standing uncertainty regarding the magnitude of venous and arterial thrombosis risk associated with low protein S. Population-scale multiomic datasets offer an unprecedented opportunity to answer questions regarding the epidemiology and clinical impacts of protein S deficiency.&lt;h4>Objective&lt;/h4>To evaluate the risk associated with protein S deficiency across multiple thrombosis phenotypes.&lt;h4>Design, setting, and participants&lt;/h4>Cross-sectional study using longitudinal population cohorts derived from the UK Biobank (n = 426 436) and the US National Institutes of Health All of Us (n = 204 006) biorepositories. UK Biobank participants were enrolled in 2006-2010 (last follow-up, May 19, 2020) and underwent</pubmed_abstract><journal>JAMA</journal><pubmed_title>Population-Scale Studies of Protein S Abnormalities and Thrombosis.</pubmed_title><pmcid>PMC11877412</pmcid><funding_grant_id>R03 HL162761</funding_grant_id><funding_grant_id>R01 HL157635</funding_grant_id><funding_grant_id>T32 HL007227</funding_grant_id><funding_grant_id>R01 HL166246</funding_grant_id><funding_grant_id>L70 HL175855</funding_grant_id><funding_grant_id>R01 HL171042</funding_grant_id><funding_grant_id>UL1 TR001863</funding_grant_id><funding_grant_id>R01 HL092577</funding_grant_id><pubmed_authors>Rodriguez Espada A</pubmed_authors><pubmed_authors>Choi SH</pubmed_authors><pubmed_authors>Ryu J</pubmed_authors><pubmed_authors>Chaudhry SA</pubmed_authors><pubmed_authors>Bauer KA</pubmed_authors><pubmed_authors>Jurgens SJ</pubmed_authors><pubmed_authors>Ellinor PT</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Bendapudi PK</pubmed_authors><pubmed_authors>Haj AK</pubmed_authors><pubmed_authors>Grover SP</pubmed_authors><pubmed_authors>Sanna-Cherchi S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Population-Scale Studies of Protein S Abnormalities and Thrombosis.</name><description>&lt;h4>Importance&lt;/h4>Clinical decision-making in thrombotic disorders is impeded by long-standing uncertainty regarding the magnitude of venous and arterial thrombosis risk associated with low protein S. Population-scale multiomic datasets offer an unprecedented opportunity to answer questions regarding the epidemiology and clinical impacts of protein S deficiency.&lt;h4>Objective&lt;/h4>To evaluate the risk associated with protein S deficiency across multiple thrombosis phenotypes.&lt;h4>Design, setting, and participants&lt;/h4>Cross-sectional study using longitudinal population cohorts derived from the UK Biobank (n = 426 436) and the US National Institutes of Health All of Us (n = 204 006) biorepositories. UK Biobank participants were enrolled in 2006-2010 (last follow-up, May 19, 2020) and underwent</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Apr</publication><modification>2026-05-29T08:33:52.954Z</modification><creation>2026-04-08T04:09:23.263Z</creation></dates><accession>S-EPMC11877412</accession><cross_references><pubmed>40029645</pubmed><doi>10.1001/jama.2025.0155</doi></cross_references></HashMap>